Table 1 Baseline characteristics of study participants treated with whole-body vibration and teriparatide compared to teriparatide alone
WBV + teriparatide group (n = 17) | teriparatide group (n = 18) | P value | |
|---|---|---|---|
Age (years) (mean ± SD) | 69 ± 5 | 69 ± 8 | 0.909 |
BMI (kg/m2)(mean ± SD) | 24.5 ± 4.1 | 24.1 ± 4.3 | 0.797 |
Charlson comorbidity score, median (IQR) | |||
Smoking, n (%) | 1 (0–1) | 0 (0–0) | 0.087 |
Current | 4 (24) | 4 (22) | 0.630 |
Former | 6 (35) | 9 (50) | |
Never | 7 (41) | 5 (28) | |
Physical activity at baseline*, n (%) | |||
Low | 10 (59) | 8 (39) | 0.421 |
moderate | 4 (23) | 8 (50) | |
High | 3 (18) | 2 (11) | |
Falls in the last 12 months¤, n (%) | |||
None | 10 (59) | 11 (61) | 0.244 |
1 | 3 (18) | 6 (33) | |
≥ 2 | 4 (24) | 1 (6) | |
Alcohol, (units a day)¤, n (%) | |||
none | 3 (18) | 6 (33) | 0.543 |
up to 1 | 11 (64) | 10 (56) | |
> 1 | 3 (18) | 2 (11) | |
Ability to rise from chair without using arms ¤, n (%) | 12 (71) | 16 (89) | 0.177 |